SOX10/keratin dual‐color immunohistochemistry: An effective first‐line test for the workup of epithelioid malignant neoplasms in FNA and small biopsy specimens

SOX10/keratin dual‐color immunohistochemistry: An effective first‐line test for the workup of... INTRODUCTIONThe timely and accurate diagnosis of poorly differentiated epithelioid neoplasms often is challenging due to a broad differential diagnosis that includes melanoma, carcinoma, and certain sarcomas with an epithelioid morphology. Thus, a panel of immunohistochemical stains covering several lineages of differentiation often is required for the precise classification of these tumors. This is especially true in the 3% to 5% of patients who present with cancer of an unknown primary site, or the growing population of patients with a history of multiple primary malignancies. As an increasing number of predictive tests for specific drugs and molecular assays have entered into routine clinical practice, the preservation of limited biopsy material is of paramount importance to identify potential targeted therapies, establish eligibility for immune checkpoint inhibitor therapy, or to allow a patient to enroll in a clinical trial. Moreover, as reimbursement structures change, rapid and accurate diagnoses that preserve limited material by minimizing the number of immunohistochemical stains – while reducing the number of biopsies specifically designated for obtaining tissue for ancillary studies – will become more important.Dual‐color immunohistochemistry (IHC) has been established as an adjunct test for the evaluation of invasive carcinoma in both the breast and prostate, and has http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Cancer Cytopathology Wiley

SOX10/keratin dual‐color immunohistochemistry: An effective first‐line test for the workup of epithelioid malignant neoplasms in FNA and small biopsy specimens

Loading next page...
 
/lp/wiley/sox10-keratin-dual-color-immunohistochemistry-an-effective-first-line-tUJjTDfhRG
Publisher
Wiley Subscription Services, Inc., A Wiley Company
Copyright
© 2018 American Cancer Society
ISSN
1934-662X
eISSN
1934-6638
D.O.I.
10.1002/cncy.21960
Publisher site
See Article on Publisher Site

Abstract

INTRODUCTIONThe timely and accurate diagnosis of poorly differentiated epithelioid neoplasms often is challenging due to a broad differential diagnosis that includes melanoma, carcinoma, and certain sarcomas with an epithelioid morphology. Thus, a panel of immunohistochemical stains covering several lineages of differentiation often is required for the precise classification of these tumors. This is especially true in the 3% to 5% of patients who present with cancer of an unknown primary site, or the growing population of patients with a history of multiple primary malignancies. As an increasing number of predictive tests for specific drugs and molecular assays have entered into routine clinical practice, the preservation of limited biopsy material is of paramount importance to identify potential targeted therapies, establish eligibility for immune checkpoint inhibitor therapy, or to allow a patient to enroll in a clinical trial. Moreover, as reimbursement structures change, rapid and accurate diagnoses that preserve limited material by minimizing the number of immunohistochemical stains – while reducing the number of biopsies specifically designated for obtaining tissue for ancillary studies – will become more important.Dual‐color immunohistochemistry (IHC) has been established as an adjunct test for the evaluation of invasive carcinoma in both the breast and prostate, and has

Journal

Cancer CytopathologyWiley

Published: Jan 1, 2018

Keywords: ; ; ; ; ; ; ; ; ;

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial